Effects of topical anandamides on intraocular pressure in normotensive rabbits

Life Sciences

Volumn 58, Issue 21, 1996, Pages 1849-1860

  Pate, David W ^a   Järvinen, Kristiina ^d   Urtti, Arto ^d   Jarho, Pekka ^d   Fich, Mette ^b   Mahadevan, Vaidyanath ^c   Järvinen, Tomi ^d  

^a HortaPharm BV   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Deva Biotech Inc   (United States)

^d NONE

Author keywords

amandamides; cyclodextrin; indomethacin; intraocular pressure; rabbit

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANANDAMIDE; ANANDAMIDE DERIVATIVE; ARACHIDONIC ACID; ARACHIDONYL ALLYLAMIDE; ARACHIDONYL AMINOETHYLAMIDE; ARACHIDONYL BUTANOLAMIDE; ARACHIDONYL ETHYLMORPHOLINAMIDE; ARACHIDONYL FLUOROETHYLAMIDE; ARACHIDONYL HEXANOLAMIDE; ARACHIDONYL METHOXYETHYLAMIDE; ARACHIDONYL MORPHOLINAMIDE; ARACHIDONYL N ACETYLAMINOETHYLAMIDE; ARACHIDONYL N,N DIMETHYLAMINO ETHYLAMIDE; ARACHIDONYL PENTANOLAMIDE; ARACHIDONYL PHENETHYLAMIDE; ARACHIDONYL PROPANOLAMIDE; ARACHIDONYL PROPARGYLAMIDE; ARACHIDONYL PROPIONITRILEAMIDE; ARACHIDONYL PROPYLAMIDE; ARACHIDONYL PYRIDINOETHYLAMIDE; INDOMETACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR PRESSURE; MALE; MASS SPECTROMETRY; NONHUMAN; RABBIT; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 15844412032     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00169-5     Document Type: Article

References (44)

1. R.S. HEPLER and M. FRANK, J. Am. Med. Assn. 217 1392 (1971).
2. J.C. MERRITT, S. MCKINNON, J.R. ARMSTRONG, G. HATEM AND L.A. REID, Ann. Ophthalmol. 12 947-950 (1980).
3. P. COOLER AND J.M. GREGG, South. Med J. 70 951-954 (1977).
4. J.G. MERRITT, R. WHITAKER, C.J. PAGE, J.H. PEACE, R.C. GRIMSON, J.L. OLSEN, R.L. PEIFFER AND R. DAVANZO, Glaucoma 4 253-255 (1982).
5. K. GREEN, C.M. SYMONDS, N.W. OLIVER AND R.D. ELIJAH, Curr. Eye Res. 2 247-253 (1983).
6. B.K. COLASANTI, S.R. POWELL AND C.R. CRAIG, Exp. Eye Res. 38 63-71 (1984).
7. M.A. ELSOHLY, E.C. HARLAND, D.A. BENIGNI and C.W. WALLER, Curr. Eye Res. 3 841-850 (1984).
8. B.K. COLASANTI, J. Ocul. Pharmacol. 6 259-269 (1990).
9. S. MUCHTAR, S. ALMOG, M.T. TORRACCA, M.F. SAETTONE and S. BENITA, Ophthalmic Res. 24 142-149 (1992).
10. S.J. WARD and M.R. BELL, US patent 5,013,837. May 7, 1991.
11. S.J. WARD, US Patent 5,081,122. January 14, 1992.
12. W.A. DEVANE, L. HANUS, A. BREUER, R.G. PERTWEE, L.A. STEVENSON, G. GRIFFIN, D. GIBSON, A. MANDELBAUM, A. ETINGER and R. MECHOULAM. Science 258 1946-1949 (1992).
13. J.N. CRAWLEY, R.L. CORWIN, J.K. ROBINSON, C.C. FELDER, W.A. DEVANE and J. AXELROD, Pharmacol. Biochem. Behav. 46 967-972 (1993).
14. E. FRIDE and R. MECHOULAM, Eur. J. Pharmacol. 231 313-314 (1993).
15. D.E. JOHNSON, S.L. HEALD, R.D. DALLY and R.A. JANIS, Prostagl. Leukotr. Essen. Fatty Acids 48 429-437 (1993).
16. Z. VOGEL, J. BARG, R. LEVY, D. SAYA, E. HELDMAN, and R. MECHOULAM, J. Neurochem. 61 352-355 (1993).
17. P.B. SMITH, D.R. COMPTON, S.P. WELCH, R.K. RAZDAN, R. MECHOULAM and B.R. MARTIN, J. Pharmacol. Exp. Therap. 270 219-227 (1994).
18. L. HANUS, A. GOPHER, S. ALMOG and R. MECHOULAM, J. Med. Chem. 36 3032-3034 (1993).
19. V. ABADJI, S. LIN, G. TAHA, G. GRIFFEN, L.A. STEVENSON, R.G. PERTWEE and A. MAKRIYANNIS, J. Med. Chem. 37 1889-1893 (1994).
20. I.R. ADAMS, W. RYAN, M. SINGER, R.K. RAZDAN, D.R. COMPTON and B.R. MARTIN, Life Sci. 56 2041-2048 (1995).
21. C.C. FELDER, E.M. BRILEY, J. AXELROD, J.T. SIMPSON, K. MAKIE and W.A. DEVANE, Proc. Nat. Acad. Sci. (USA) 90 7656-7660 (1993).
22. J.C. PINTO, F. POTIE, K.C. RICE, D. BORING, M.R. JOHNSON, D.M. EVANS, G.H. WILKEN, C.H. CANTRELL and A.C. HOWLETT, Mol. Pharmacol. 46 516-522 (1994).
23. S.P. WELCH, L.D. DUNLOW, G.S. PATRICK and R.K. RAZDAN, J. Pharmacol. Exp. Therap. 273 1235-1244 (1995).
24. C.M. GERARD, C. MOLLEREAU, G. VASSART and M. PARTMENTER, Biochem. J. 279 129-134 (1991).
25. N.E. KAMINSKI, N.E. ABOOD, F.K. KESSLER, B.R. MARTIN and A.R. SCHANTZ, Mol. Pharmacol. 42 736-742 (1992).
26. S. MONRO, K.L. THOMAS and M. ABU-SHAAR, Nature 365 61-65 (1993)
27. R. MECHOULAM, S. BEN-SHABAT, L. HANUS, M. LIGUMSKY, N.E. KAMINSKI, A.R. SCHATZ, A. GOPHER, S. ALMOG, B.R. MARTIN, D.R. COMPTON, R.G. PERTWEE, G. GRIFFEN, M. BAYEWITCH, J. BARG, and Z. VOGEL, Biochem. Pharmacol. 50 83-90 (1995).
28. A.B. LYNN and M. HERKENHAM, J. Pharmacol. Exp. Therap. 268 1612-1623 (1994).
29. S. GALIÈGUE, S. MARY, J. MARCHAND, D. DUSSOSSOY, D. CARRIÈRE, P. CARAYON, M. BOUABOULA, D. SHIRE, G. LE FUR and P. CASELLAS, Eur. J. Biochem. 232 54-61 (1995).
30. D.W. PATE, K. JARVINEN, A. URTTI, P. JARHO and T. JARVINEN, Curr. Eye Res. 14 791-797 (1995).
31. W. DEVANE, R. MECHOULAM, A. BEUER and L. HANUS, PCT/US93/11625, June 9, 1994.
32. C.S.J. WALPOLE, R. WRIGGLESWORTH, S. BEVAN, E.A. CAMPBELL, A. DRAY, I.F. JAMES, M.N. PERKINS, D.J. REID and J. WINTER, J. Med. Chem. 36 2362-2372 (1993).
33. S.M. PODOS, B. BECKER AND M.A. KASS, Invest. Ophthalmol. 12 426-433 (1973).
34. S.M. PODOS, B. BECKER AND M.A. KASS, Prostaglandins 3 7-16 (1973).
35. J. SZEJTLI, Med. Res. Rev. 14 353-386 (1994).
36. T. HIGUCHI and K.A. CONNERS, Adv. Anal. Chem. Instr. 4 117-212 (1965).
37. I.B. ADAMS, W. RYAN, M. SINGER, B.F. THOMAS, D.R. COMPTON, R.K. RAZDAN and B.R. MARTIN, J. Pharmacol. Exp. Therap. 273 1172-1181 (1995).
38. S.C. CHANG and V.H.L. LEE, J. Ocul. Pharmacol. 3 159-169 (1987).
39. A. URTTI and L. SALMINEN, Surv. Ophthalmol. 37 435-457 (1993).
40. L. SALMINEN and A. URTTI, Exp. Eye Res. 38 203-206 (1984).
41. A. URTTI and L. SALMINEN, Acta Ophthalmol. 63 156-18 (1985).
42. M. WARTMANN, D. CAMPBELL, A. SUBRAMANIAN, S.H. BURSTEIN and R.J. DAVIS, F.E.B.S. Lett. 359 133-136 (1995).
43. C.B. CAMRAS, S.G. FELDMAN, S.M. PODOS, R.E. CHRISTENSEN, S.K. GARDNER and D.T. FAZIO, Am. J. Ophthalmol. 100 169-175 (1985).
44. P. BHATTACHERJEE and B.R. HAMMOND, Exp. Eye Res. 24 307-313 (1977).